[HTML][HTML] 2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association - Korean Journal of Radiology, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches

G Sapisochin, J Bruix - Nature reviews Gastroenterology & hepatology, 2017 - nature.com
Liver transplantation for hepatocellular carcinoma (HCC) is the best treatment option for
patients with early-stage tumours and accounts for∼ 20–40% of all liver transplantations …

[HTML][HTML] Hepatocellular carcinoma: A comprehensive review

LP Waller, V Deshpande… - World journal of …, 2015 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is rapidly becoming one of the most prevalent cancers
worldwide. With a rising rate, it is a prominent source of mortality. Patients with advanced …

[HTML][HTML] 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association - Korean Journal of Radiology, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

[HTML][HTML] Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation

NA Filgueira - World journal of hepatology, 2019 - ncbi.nlm.nih.gov
Liver transplantation is the best treatment option for cirrhotic patients with early-stage
hepatocellular carcinoma, but it faces the problem of scarcity of donors and the risk of tumor …

2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

JW Park, JS Lee, KS Suh, JW Chung, J Seong… - Gut and …, 2019 - scholarworks.bwise.kr
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

[HTML][HTML] 2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma

Korean Liver Cancer Study Group - 2015 - gutnliver.org
2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular
Carcinoma Login to Submission Gut and Liver 2021 Impact Factor 4.321 Indexed In …

Evaluation of the intention-to-treat benefit of living donation in patients with hepatocellular carcinoma awaiting a liver transplant

Q Lai, G Sapisochin, A Gorgen, A Vitale… - JAMA …, 2021 - jamanetwork.com
Importance Living-donor liver transplant (LDLT) offers advantages over deceased-donor
liver transplant (DDLT) of improved intention-to-treat outcomes and management of the …

Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation

N Goldaracena, A Gorgen, A Doyle, BE Hansen… - Journal of …, 2019 - Elsevier
Background & Aims There are conflicting reports on the outcomes after live donor liver
transplantation in patients with hepatocellular carcinoma (HCC). We aimed to compare the …

Overview of the indications and contraindications for liver transplantation

S Farkas, C Hackl, HJ Schlitt - Cold Spring …, 2014 - perspectivesinmedicine.cshlp.org
Liver transplantation is the only definitive treatment option for patients with irrevocable acute
or chronic liver failure. In the last four decades, liver transplantation has developed from an …